JCJoshua D. Campbell

Joshua D. Campbell

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joshua D. Campbell has a total of 700 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Trisomy 21 Perturbs Oligodendrocyte Developmental States and Oligo–Neuron Communication in Human Forebrain Assembloids

    by Ella Zeldich, Natalie Campbell, Sonal Khanna, Michelle Kim, Elizabeth Kharitonova, Maya Weidman, Cody Headings, Nathan Chai, Clara Chung, Samantha Chung, et al.

    Intellectual disability is a hallmark of Down syndrome (DS), caused by the triplication of human chromosome 21. Abnormal neuronal connectivity and impaired myelination are consistently observed in DS, yet the underlying mechanisms remain poorly understood. Here, we used DS-derived isogenic induced pluripotent stem cell-derived forebrain assembloids (FAs) to investigate oligodendrocyte lineage cell (OLLC) development and neuron–glia interactions. Trisomic FAs exhibited an expansion of BCAS1+ pre-myelinating OLLCs, without a corresponding increase in myelin basic protein (MBP) expression. Transcriptomic analyses identified a euploid-enriched, trophic and maturation-supportive state (OLLC_2-TMS) and a trisomy-enriched synaptic interactions and differentiation state (OLLC_3-SID), lacking coordinated enrichment in myelination-promoting programs. Corresponding transcriptional signatures were identified in OLLCs from early postnatal human cortex. Increased excitatory neuronal contacts with pre-myelinating OLLCs accompanied ultrastructural myelin abnormalities in trisomic assembloids. Our findings suggest that trisomy redirects OLLC development toward a pre-myelinating state, uncoupling oligodendrocyte differentiation from productive myelination.

  • Open Access

    Characterizing Multimodal Mutational Processes in Cancer Using MOTET

    by Jiaqi Sun, Kelly L. Geyer, Natasha Q. Gurevich, Tao Guo, Masanao Yajima, Jonathan H. Huggins, Joshua D. Campbell

    Mutational signatures are characteristic patterns of somatic alterations in cancer genomes. A single aberrant mechanism can simultaneously generate coordinated patterns of alterations across multiple mutation modalities, including single-base substitutions (SBSs), doublet-base substitutions (DBSs), and small insertions and deletions (IDs). However, these signatures are typically inferred separately and linked post hoc , obscuring their shared underlying mechanisms. To resolve this, we formally define a Mutational Process (MP) as a unified latent activity that induces coupled mutational signatures across these modalities. We developed MOTET, a Bayesian framework that jointly infers multimodal MPs. Applied to 2,583 whole genomes from the PCAWG cohort, MOTET recovers known MPs more accurately than standard post hoc correlation methods. MOTET also identifies a process linking an SBS37-related signature with a TG>CA-dominated DBS component and resolves canonical SBS12-like activity into two separate MPs with distinct tissue distributions. These results establish a paradigm for formally defining catalogs of MPs and demonstrate that integrating across modalities enhances the ability to discover new mutational patterns.

  • Open Access

    Trisomy 21 Perturbs Oligodendrocyte Developmental States and Oligo–Neuron Communication in Human Forebrain Assembloids

    by Natalie Baker Campbell, Sonal Khanna, Michelle J Kim, Elizabeth K Kharitonova, Maya P Weidman, Cody Headings, Nathan X Chai, Clara Chung, Samantha Chung, Grace Field, et al.

    Intellectual disability is a hallmark of Down syndrome (DS), caused by the triplication of human chromosome 21. Abnormal neuronal connectivity and impaired myelination are consistently observed in DS, yet the underlying mechanisms remain poorly understood. Here, we used DS-derived isogenic induced pluripotent stem cell-derived forebrain assembloids (FAs) to investigate oligodendrocyte lineage cell (OLLC) development and neuron–glia interactions. Trisomic FAs exhibited an expansion of BCAS1+ pre-myelinating OLLCs, without a corresponding increase in myelin basic protein (MBP) expression. Transcriptomic analyses identified a euploid-enriched, trophic and maturation-supportive state (OLLC_2-TMS) and a trisomy-enriched synaptic interactions and differentiation state (OLLC_3-SID), lacking coordinated enrichment in myelination-promoting programs. Corresponding transcriptional signatures were identified in OLLCs from early postnatal human cortex. Increased excitatory neuronal contacts with pre-myelinating OLLCs accompanied ultrastructural myelin abnormalities in trisomic assembloids. Our findings suggest that trisomy redirects OLLC development toward a pre-myelinating state, uncoupling oligodendrocyte differentiation from productive myelination.

  • Open Access

    PGC-1α agonism via oral administration of ZLN005 induces fetal hemoglobin and is antisickling in sickle mice

    by Hajar Benmhammed, Yanan Sun, Salam AlAbdullatif, Andrew Chen, Serena Khan, Anais Mortazavi Zadeh, Noundy Mazile, Gwendolyn M. Beacham, Kiana Mahdaviani, Christopher Williams, et al.

    Sickle cell disease (SCD), caused by a point mutation in the β-globin gene (HBB), results in the production of sickle hemoglobin (HbS). Deoxy-HbS polymerizes, deforming red blood cells (RBCs) and leading to a cascade of clinical complications, including vaso-occlusion, hemolysis, inflammation, and progressive organ damage. An effective strategy to mitigate disease severity is the reactivation of fetal hemoglobin (HbF), which interferes with HbS polymerization. We explored the therapeutic potential of ZLN005, a small-molecule activator of the transcriptional coactivator PGC-1α (peroxisome proliferator–activated receptor gamma coactivator 1-α), by evaluating its impact on HbF induction in CD34+ hematopoietic progenitor cells derived from patients with SCD, in β-YAC transgenic mice carrying a normal human HBB cluster, and in SCD mice. ZLN005 increased γ-globin expression and HbF+ cells without impairing erythroid differentiation of CD34+ cells. Oral administration of ZLN005 to SCD mice increased HbF+ cells, reduced sickled RBCs, increased hemoglobin levels, lowered reticulocyte counts, and decreased spleen and liver pathology related to SCD. ZLN005 or related compounds could represent a promising new class of orally available HbF-inducing therapeutics.

  • Spatially Resolved Heterogeneity of Lymphatic Vasculature in the Adult Lung—Brief Report

    by Erin Crossey, Senegal Carty, Isabella Garza, Meliza Perez, Fengzhi Shao, Salam Al Abdullatif, Joshua D. Campbell, Joseph P. Mizgerd, Alan Fine, Matthew R. Jones

    BACKGROUND: Lung lymphatic drainage of interstitial fluid is essential for preventing pulmonary edema, a condition characterized by the accumulation of extravascular fluid that impedes respiratory gas exchange and can be fatal. Beyond fluid regulation, lung lymphatics also serve as conduits for immune cell trafficking, supporting both surveillance and mounting of host immune responses during lung infection. Despite their essential roles, the cellular and functional heterogeneity of lung lymphatic endothelial cells (LECs) remains poorly defined. METHODS: Leveraging single-nucleus sequencing technology, we investigated LEC heterogeneity in the homeostatic adult mouse lung. RESULTS: We identified Stab2 (stabilin-2), a class H scavenger receptor, as a unique marker of a distinct subset of LECs in lymphatic vessels adjacent to pulmonary veins and in alveolar regions. A separate, distinct subset of LECs is defined by expression of Pkhd1l1 (polycystic kidney and hepatic disease 1-like-1), a component of stereocilia, and these lymphatic vessels are localized to the bronchovascular bundle. CONCLUSIONS: Our findings suggest that lung LECs are not a uniform population but instead comprise molecularly distinct and spatially organized lymphatic vessels, possibly with specialized functions. These results lay the groundwork for further studies geared toward understanding the roles of cellular origin in lung LEC heterogeneity, whether lymphatics in other organs have analogous spatial organization, and whether these disparate cells and vessels have functional differences in fluid homeostasis and immune regulation during pulmonary disease pathogenesis.


  • Open Access

    Benchmarking of local ancestry inference with different assays and parameters

    by Tomoki Motegi, Franklin Huang, Joshua D. Campbell

    Local ancestry inference (LAI) enables high-resolution characterization of chromosomal segments inherited from distinct ancestral populations, offering unique insights into genetic architecture in admixed cohorts. While LAI is commonly performed with high-coverage whole-genome sequencing (WGS), the ability of other genotyping assays or varying sequencing depths has not been thoroughly benchmarked. In this study, we systematically evaluated the accuracy of LAI across SNP microarrays, whole-exome sequencing (WES), and ultra low-pass WGS (ULP-WGS) using diverse validation samples and state-of-the-art imputation pipelines. We show that ULP-WGS, when paired with GLIMPSE2, achieves robust accuracy at 0.25x coverage with a minimum genome window size of 0.5 centimorgans, with mean accuracy minus one standard deviation exceeding 95%. For WES, using “on-target” reads alone yields suboptimal performance, particularly for European and South Asian ancestries with accuracy less than 79.1% and 70.6%, respectively. However, incorporating “off-target” reads in WES and utilizing GLIMPSE2 substantially improved accuracy ≥95% with a minimum window size of 0.2 centimorgans. We further evaluated formalin-fixed, paraffin-embedded (FFPE) samples and found that LAI could be performed successfully using WES data with accuracies of ≥95% at a minimum window size of 0.5 centimorgans. In contrast, SNP microarrays did not achieve substantial accuracies at any window size (≤95%). Together, these results demonstrate that LAI is achievable without conventional high-coverage WGS and establish optimal parameters for LAI across platforms.

  • Open Access

    Defining the combinatorial nature of gene modules in prostate cancer underlying lineage plasticity and metastasis

    by Franklin Huang, Hanbing Song, Junxiang Xu, Keila Velazquez-Arcelay, Arda Demirci, Brendan Raizenne, Sarah Hsu, Joshua Choi, Julia Pham, Yih-An Chen, et al.

    Prostate cancer encompasses a spectrum of disease states driven by complex cellular heterogeneity. To delineate the transcriptional programs underlying lineage plasticity and metastasis, we constructed a comprehensive single-cell atlas of 128 patients, spanning localized, castration-resistant, and metastatic disease. Lineage plasticity was prevalent in localized disease, with subsets of tumor cells adopting distinct basal-like and club-like states. Luminal-like cancer cells also displayed extensive lineage infidelity, defined not by a binary loss of identity but by the combinatorial erosion of luminal gene modules associated with higher grade and stage. In the metastatic setting, gene program association analysis (GPAS) identified a broad induction of cell-cycle gene modules across organ sites as well as an induction of organ-specific gene modules, including osteomimetic signaling in bone, neuro-migratory genes in brain, and erythroid-like transitions in liver. Neuroendocrine prostate cancers (NEPCs) were not monolithic but defined by combinations of NE-associated gene modules including a novel HES6 program. Notably, these modules were detected at intermediate levels in localized samples, suggesting molecular plasticity precedes histological transformation. We also developed a refined NE signature that could distinguish NEPC tumors more accurately than previously published signatures. Within the tumor microenvironment (TME), we observed an elevation of pro-inflammatory Th17 T-cells in African American patients and identified a rare Schwann cell population. Finally, we present PCformer, a transformer-based foundation model trained on >500,000 cells to automate cell-state classification. Together, this comprehensive atlas demonstrates the complex nature of gene modules underlying lineage infidelity and plasticity in cancer cells and highlights distinct immune and stromal populations within the tumor ecosystem.

  • Open Access

    Endothelial Erg Regulates Expression of Pulmonary Lymphatic Junctional and Inflammation Genes in Mouse Lungs Impacting Lymphatic Transport

    by Adri Chakraborty, Alex Kim, Salam AlAbdullatif, Joshua Campbell, Yuriy Alekseyev, Ulas Kaplan, Vrinda Dambal, Giovanni Ligresti, Maria Trojanowska

    The ETS transcription factor ERG is a master regulator of endothelial gene specificity and highly enriched in the capillary, vein, and arterial endothelial cells. ERG expression is critical for endothelial barrier function, permeability, and vascular inflammation. A dysfunctional vascular endothelial ERG has been shown to impair lung capillary homeostasis, contributing to pulmonary fibrosis as previously observed in IPF lungs. Our preliminary observations indicate that lymphatic endothelial cells (LEC) in the human IPF lung also lack ERG. To understand the role of ERG in pulmonary LECs, we developed LEC-specific inducible Erg-CKO and Erg-GFP-CKO conditional knockout (CKO) mice under Prox1 promoter. Whole lung microarray analysis, flow cytometry, and qPCR confirmed an inflammatory and pro-lymphvasculogenic predisposition in Erg-CKO lung. FITC-Dextran tracing analysis showed an increased pulmonary interstitial lymphatic fluid transport from the lung to the axial lymph node. Single-cell transcriptomics confirmed that genes associated with cell junction integrity were downregulated in Erg-CKO pre-collector and collector LECs. Integrating Single-cell transcriptomics and CellChatDB helped identify LEC specific communication pathways contributing to pulmonary inflammation, trans-endothelial migration, inflammation, and Endo-MT in Erg-CKO lung. Our findings suggest that downregulation of lymphatic Erg crucially affects LEC function, LEC permeability, pulmonary LEC communication pathways and lymphatic transcriptomics.

  • Open Access

    Figure S7 from Upregulation of an Epithelial miRNA Is Associated with Immune Evasion in Progressive Bronchial Premalignant Lesions

    by Boting Ning, Darren J. Chiu, Roxana M. Pfefferkorn, Erin Cullinane, Yohana Kefella, Erin Kane, Valerie Reyes-Ortiz, Gang Liu, Xiaohui Zhang, Hanqiao Liu, et al.

    Supplementary Figure S7. Performance of the hsa-miR-149-5p spot detection classifier.

  • Open Access

    Figure S5 from Upregulation of an Epithelial miRNA Is Associated with Immune Evasion in Progressive Bronchial Premalignant Lesions

    by Boting Ning, Darren J. Chiu, Roxana M. Pfefferkorn, Erin Cullinane, Yohana Kefella, Erin Kane, Valerie Reyes-Ortiz, Gang Liu, Xiaohui Zhang, Hanqiao Liu, et al.

    Supplementary Figure S5. Flow cytometry experiment details.